GLP-1 FDA records, October 2026

In October 2026, FDA issued 1 warning letter naming a GLP-1 drug tracked here (September: 3) and posted 2 letters it had issued earlier. openFDA lists 10 recall reports for compounded or unapproved GLP-1 products with an FDA report date in October, from 3 firms (September: 0). The index holds 3 dated FDA statements from October 2026. This report was frozen on Nov 4, 2026 and does not change when the records are refreshed.

Counts against September 2026

RecordOctober 2026September 2026
FDA warning letters issued13
Letters posted this month, issued earlier25
Recall reports with an FDA report date this month100
Recall reports initiated this month010
503B facilities with a last inspection this month09
Dated FDA statements30
Federal Register documents00

Prior-month counts were taken from the records on the day this report was frozen, Nov 4, 2026. FDA posts some letters weeks after it issues them, so a later count for a past month can be higher.

FDA warning letters issued in October 2026

Later letters FDA listsLetter
Oct 30, 2026RonanRx, Inc. dba RonanRxFalse & Misleading Claims/Misbranded (Telehealth)Semaglutide, TirzepatideNone listed by FDA as of Nov 15, 2026fda.gov

A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.

Letters FDA posted in October 2026 that were issued earlier

Later letters FDA listsLetter
Sep 24, 2026Cheap Medicine Shop/www.cheapmedicineshop.comUnapproved New Drugs/Misbranded (Internet Pharmacy)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov
Sep 23, 2026Online Generic Medicine/www.onlinegenericmedicine.comUnapproved New Drug/Misbranded (Internet Pharmacy)SemaglutideNone listed by FDA as of Nov 15, 2026fda.gov

A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.

Recall reports with an FDA report date in October 2026

Record
Sep 25, 2026Houston Rx LLCTirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.Lack of assurance of sterility.Class IIOngoingD-0040-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infus...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0017-2027
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE 3 MG/ML INJECTABLE, 8 x 0.1 mL syringes, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0018-2027
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE/CYANOCOBALAMIN 3/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0019-2027
Sep 10, 2026Carolina Infusion, LLCSEMAGLUTIDE/CYANOCOBALAMIN 9/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0026-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 26/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0027-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 64/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0028-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 76/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0029-2027
Sep 10, 2026Carolina Infusion, LLCTIRZEPATIDE/CYANOCOBALAMIN 85/2 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescriptio...Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.Class IIOngoingD-0030-2027
Sep 24, 2026Apothecary Pharma LLCTirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.Lack of Assurance of SterilityClass IIOngoingD-0036-2027

503B facility inspections

No facility on FDA’s 503B list showed a last inspection date in October 2026 when this report was frozen.

Dated FDA statements

FDA’s page does not date each paragraph; the date shown is the page’s “content current as of” date.

This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.

Sources

Records last pulled Nov 4, 2026. Every entry links to the original public record.